{"ticker": {"uuid": "836e63da-349c-4861-ae9b-551873d9b2de", "symbol": "SION", "name": "Sionna Therapeutics, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Sionna Therapeutics Inc. (SION) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUkFVX3lxTE5uUUFrVjJCeEk4c2VFdFlMSkZTMlBHSEhTb0JTdko0TW4wekd2WkkwOVpHNGlmRWpyZWxJdGYtVWlHbDNYYUFidDRtYW83QXhUNmc?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-20T17:55:03+00:00", "published_display": "20 Jul 2026 17:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics (SION) Stock Looks Pricey On Assets But Strong On Returns", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-19T03:38:58+00:00", "published_display": "19 Jul 2026 03:38", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SION Stock Jumps As Traders Bet On High-Volatility Setup", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQNkpaS2o0MzNldnlzVF9XX01vcVVZVnRZczIzX0pKeEZRQ1B2aDZPeVhOa2E5QWk3TjhyckJNem1tazZqSzRlb29aaWFQSzhwLTFXSDRkM1ZadVpkUkhQaGR0T1V6OGRQNloyUHpSUnBZalpyZnZsczZRY2lZQUxYMGxDVQ?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-18T14:08:00+00:00", "published_display": "18 Jul 2026 14:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SION Jumps As Sionna Therapeutics Draws Trader Attention", "summary": "Sionna Therapeutics Inc. (SION) stock has surged by 11.26% due to positive cystic fibrosis drug development news. Despite being a pre-revenue biotech with negative earnings and cash burn, its strong balance sheet with low debt and high liquidity makes it a high-risk, high-reward ", "url": "https://stockstotrade.com/news/sionnatherapeuticsinc-sion-news-2026_07_18/", "source_name": "StocksToTrade", "published_at": "2026-07-18T12:09:22", "published_display": "18 Jul 2026 12:09", "sentiment": "positive", "sentiment_pct": 73, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SION Jumps As Sionna Therapeutics Stock Extends Breakout", "summary": "Sionna Therapeutics Inc. (SION) stock jumped over 11% following positive developments in its cystic fibrosis pipeline, signaling increased investor confidence. The stock showed strong technical breakout from the low-$40s to the $50 area, driven by aggressive buying and short cove", "url": "https://stockstotrade.com/news/sionnatherapeuticsinc-sion-news-2026_07_18-2/", "source_name": "StocksToTrade", "published_at": "2026-07-18T11:48:00", "published_display": "18 Jul 2026 11:48", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$SION stock is up 9% today. Here's what we see in our data.", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQZ29sbnA0azBRVEh1b1Vqci0tS3lUdjRoMjZUUzg0ZnBtcXpJcFZKRmRVaExkRzl5UjBOTlF6R2xlbk9hbnNuWWhJS3BSYjZwbWp3QUNONXlicEltaEJtQlhIUzlPdGJBNjFMYlh2a3JqdXpRb2syMFBYZ2pCXzNTcy1oUGw3SFU5OGNNYi03V1IyaW5ZXzFSNXdQenN2WlE?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-17T19:23:00+00:00", "published_display": "17 Jul 2026 19:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics (SION) Sees 9.2% Surge in Stock Price", "summary": "Sionna Therapeutics (SION) experienced a 9.2% surge in its stock price, reaching $49.44, driven by positive investor sentiment and developments in its biotechnology focus on cystic fibrosis treatments. Despite this gain, the company holds a low GF Score\u2122 of 12/100, indicating pro", "url": "https://www.gurufocus.com/news/8964925/sionna-therapeutics-sion-sees-92-surge-in-stock-price?mobile=true", "source_name": "GuruFocus", "published_at": "2026-07-17T18:39:32", "published_display": "17 Jul 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics stock hits all-time high at 48.66 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQSHR3bHRtc1BuRWtWSk1ZbFBVanBFUTQxdU5yUml4aDU3ZVl4bTNMM2tmMjVQeWt4OC00S3ZtUlV2QjVEWEdrN2VISXVVSUI5NWlOZlROeHE5MEoxRkxWLUFoZm9HZ3pjdkJlYkxyVVhlR3JFWDNCUEFJN3FYWGI1NllUbUdfV2I5elk0OWFLZnpHTmJ6UXQ5clduaU0xRjd5S0gtNDJ6Tl9xMjlwMlpCS1FR?oc=5", "source_name": "Investing.com", "published_at": "2026-07-17T16:22:08+00:00", "published_display": "17 Jul 2026 16:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics stock hits all-time high at 48.66 USD By Investing.com", "summary": "Sionna Therapeutics (SION) stock has reached an all-time high of $48.66, marking a 147% total return over the past year and achieving a market capitalization of $2.04 billion. Analyst ratings vary, with Citizens and Stifel maintaining \"Outperform\" and \"Buy\" ratings respectively, ", "url": "https://m.za.investing.com/news/stock-market-news/sionna-therapeutics-stock-hits-alltime-high-at-4866-usd-93CH-4374753?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-07-17T15:39:32", "published_display": "17 Jul 2026 15:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Orbimed Advisors LLC Reduces Stake in Sionna Therapeutics Inc", "summary": "Orbimed Advisors LLC recently reduced its stake in Sionna Therapeutics Inc by selling 85,918 shares at $44.86 per share. Despite this reduction, Sionna Therapeutics remains a significant holding (2.2% of the portfolio) for Orbimed, a healthcare investment firm with $15 billion in", "url": "https://www.gurufocus.com/news/8961467/orbimed-advisors-llc-reduces-stake-in-sionna-therapeutics-inc?mobile=true", "source_name": "GuruFocus", "published_at": "2026-07-16T01:42:13", "published_display": "16 Jul 2026 01:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics, Inc. Common Stock (SION) Stock Price Today: $42.59", "summary": "This article provides details on Sionna Therapeutics, Inc. (SION) stock, including its current price of $42.59 and key financial fundamentals like market capitalization ($1.98B) and P/E ratio. It also outlines how to buy SION stock through the Gotrade app, explains that SION does", "url": "https://www.heygotrade.com/en/us-stock/sion/", "source_name": "Gotrade", "published_at": "2026-07-15T03:48:05", "published_display": "15 Jul 2026 03:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics(SION.US) Director Sells US$3.85 Million in Common Stock", "summary": "A director at Sionna Therapeutics (SION.US) recently sold common stock valued at US$3.85 million. This insider transaction indicates a significant divestment by a key individual associated with the company. Investors often monitor such sales for insights into a company's financia", "url": "https://www.moomoo.com/news/post/72735499/sionna-therapeutics-sionus-director-sells-us-3-85-million-in", "source_name": "Moomoo", "published_at": "2026-07-10T09:10:58", "published_display": "10 Jul 2026 09:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Sionna Therapeutics Inc For: 9 July By Investing.com", "summary": "This article announces a Form 4 filing for Sionna Therapeutics Inc. on July 9th, as reported by Investing.com. It is a brief, factual announcement without further details within the main article text, which primarily serves as a placeholder for the filing. The article is part of ", "url": "https://ng.investing.com/news/stock-market-news/form-4-sionna-therapeutics-inc-for-9-july-93CH-2593942", "source_name": "Investing.com Nigeria", "published_at": "2026-07-10T02:09:28", "published_display": "10 Jul 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics Insider Sold Shares Worth $3,854,281, According to a Recent SEC Filing", "summary": "This article reports that an insider at Sionna Therapeutics sold shares valued at $3,854,281. This information is based on a recent SEC filing. The company is Sionna Therapeutics.", "url": "https://www.moomoo.com/news/post/72735705/sionna-therapeutics-insider-sold-shares-worth-3854281-according-to-a", "source_name": "Moomoo", "published_at": "2026-07-09T22:40:55", "published_display": "09 Jul 2026 22:40", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics (SION) Jefferies Global Healthcare Conference 2026 Summary", "summary": "Sionna Therapeutics presented at the Jefferies Global Healthcare Conference 2026, outlining its strategy to revolutionize cystic fibrosis treatment by targeting the NBD1 region of the CFTR protein. The company highlighted its scientific approach with differentiated NBD1 stabilize", "url": "https://quartr.com/events/sionna-therapeutics-sion-jefferies-global-healthcare-conference-2026_F6UlgRPm", "source_name": "Quartr", "published_at": "2026-07-09T10:42:13", "published_display": "09 Jul 2026 10:42", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Sionna Therapeutics Inc For: 7 July By Investing.com", "summary": "This article from Investing.com is a regulatory filing update, announcing the Form 4 for Sionna Therapeutics Inc. The filing date is listed as July 7. The content is primarily a placeholder for the filing, mentioning the company's stock symbol SION.", "url": "https://ng.investing.com/news/stock-market-news/form-4-sionna-therapeutics-inc-for-7-july-93CH-2589853", "source_name": "Investing.com Nigeria", "published_at": "2026-07-08T08:40:44", "published_display": "08 Jul 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics CLO Jennifer Fitzpatrick sells $446k in stock By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPV2NYei1CUEJvYzhQMm41NEFrSDB3STRRaVZ2SFRicWtyQXdfenNGTlFSUU9LZ19HMUs5RDZLaWtDY3BIUXIwSjh6NUwwenhkNEFhaXZUTFdMVzQxTHZoMUtmaUg4SU80UXEyMFV3RXM5NUVnQjk3QWhDUTlZUnMtU3ZWRWRfZ0o5RFVGZkwwakNlLVk2LXVxcWg5NlBRV0FkX2IwQjhaMFh1dFp6SHV6UF9OclEyY21mcV8zQllnYTRkUWs?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T21:09:31+00:00", "published_display": "07 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics Insider Sold Shares Worth $446,862, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/sionna-therapeutics-insider-sold-shares-204144056.html", "source_name": "MT Newswires", "published_at": "2026-07-07T20:41:44+00:00", "published_display": "07 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics CLO Jennifer Fitzpatrick sells $446k in stock", "summary": "Jennifer Fitzpatrick, CLO of Sionna Therapeutics (NASDAQ:SION), sold 10,250 shares of company stock for $446,862 on July 6, 2026, after exercising options. The sale was executed under a Rule 10b5-1 trading plan, with the stock currently trading near its 52-week high and Investing", "url": "https://www.investing.com/news/insider-trading-news/sionna-therapeutics-clo-jennifer-fitzpatrick-sells-446k-in-stock-93CH-4780175", "source_name": "Investing.com", "published_at": "2026-07-07T21:40:44", "published_display": "07 Jul 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Sionna Therapeutics, Inc. Stocks", "summary": "This article lists various ETFs that include Sionna Therapeutics, Inc. (SION) stocks in their holdings. The ETFs are sorted by market value and provide details such as issuer, management style, expense ratio, AUM, price, and 3-year NAV total return. The information aims to help i", "url": "https://www.tradingview.com/symbols/NASDAQ-SION/etfs/", "source_name": "TradingView", "published_at": "2026-07-03T23:09:43", "published_display": "03 Jul 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Sionna Therapeutics Inc For: 2 July By Investing.com", "summary": "This article announces the filing of Form 4 by Sionna Therapeutics Inc. for July 2nd, as reported by Investing.com. It is a brief financial news update indicating a disclosure filing from the company to the SEC. The content provides minimal detail beyond the announcement of the f", "url": "https://uk.investing.com/news/stock-market-news/form-4-sionna-therapeutics-inc-for-2-july-93CH-4755750", "source_name": "Investing.com UK", "published_at": "2026-07-03T19:40:01", "published_display": "03 Jul 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics director Thompson sells $5.27m in stock", "summary": "Peter A. Thompson, a director at Sionna Therapeutics (NASDAQ:SION), has sold 115,844 shares of common stock for approximately $5.27 million, through a Rule 10b5-1 trading plan. This transaction, reported on June 30, 2026, occurred while the stock was trading at $45.50 per share, ", "url": "https://www.investing.com/news/insider-trading-news/sionna-therapeutics-director-thompson-sells-527m-in-stock-93CH-4774244", "source_name": "Investing.com", "published_at": "2026-07-02T21:39:41", "published_display": "02 Jul 2026 21:39", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SION - Sionna Therapeutics Inc Latest SEC Filings", "summary": "This article provides the latest SEC filings for Sionna Therapeutics Inc (SION), along with comprehensive financial data, stock performance metrics, and analyst ratings. It details the company's market capitalization, income, sales, insider and institutional ownership, and variou", "url": "https://finviz.com/stock?t=SION&ta=1&p=w&ty=lf&r=y2&page=1", "source_name": "Finviz", "published_at": "2026-07-02T06:39:41", "published_display": "02 Jul 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Sionna Therapeutics, Inc. \u2013 NASDAQ:SION", "summary": "This article focuses on the enterprise value to EBITDA forward of Sionna Therapeutics, Inc. (NASDAQ: SION). The content appears to be a financial data page from TradingView, indicating that the market for SION was closed with no trades at the time of publication.", "url": "https://www.tradingview.com/symbols/NASDAQ-SION/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T22:09:47", "published_display": "01 Jul 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Sionna Therapeutics, Inc. \u2013 NASDAQ:SION", "summary": "The article focuses on the enterprise value to revenue forward metric for Sionna Therapeutics, Inc. (NASDAQ: SION). It provides a snapshot of the company's financial overview within the health technology and biotechnology sector on the Nasdaq Stock Market. The page appears to be ", "url": "https://www.tradingview.com/symbols/NASDAQ-SION/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T21:09:48", "published_display": "01 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SION - Sionna Therapeutics Inc Options", "summary": "This article provides detailed financial data and performance metrics for Sionna Therapeutics Inc. (SION). It includes key financial figures such as market cap, income, sales, EPS, and various ratios, alongside stock performance, insider and institutional ownership, and analyst r", "url": "https://finviz.com/stock?t=SION&p=w&r=y2&ty=oc&ov=chain_strike&s=25", "source_name": "Finviz", "published_at": "2026-07-01T17:09:47", "published_display": "01 Jul 2026 17:09", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SION - Sionna Therapeutics Inc Short Interest", "summary": "This article provides a detailed overview of Sionna Therapeutics Inc. (SION)'s short interest and key financial metrics. It includes stock performance data, insider and institutional ownership percentages, and analytical figures such as P/E ratios and debt/equity. The information", "url": "https://finviz.com/stock?t=SION&ta=1&p=w&ty=si&r=y2", "source_name": "Finviz", "published_at": "2026-07-01T13:09:24", "published_display": "01 Jul 2026 13:09", "sentiment": "negative", "sentiment_pct": 38, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Sionna Therapeutics, Inc. \u2013 NASDAQ:SION", "summary": "The article focuses on the \"Price to sales forward\" metric for Sionna Therapeutics, Inc. (NASDAQ: SION). It presents this financial data point within the context of the company's profile on TradingView, indicating its relevance for investors analyzing the biotechnology sector. Th", "url": "https://www.tradingview.com/symbols/NASDAQ-SION/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T09:09:24", "published_display": "01 Jul 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics: NBD1 Stabilization Could Redefine Cystic Fibrosis Treatment (SION)", "summary": "Sionna Therapeutics is developing a novel approach to treat cystic fibrosis by stabilizing NBD1, aiming to improve CFTR function beyond existing treatments. The company has two key drug candidates, SION-719 and SION-451, both nearing significant clinical data readouts in summer 2", "url": "https://seekingalpha.com/article/4918780-sionna-therapeutics-stock-nbd1-stabilization-could-redefine-cystic-fibrosis-treatment", "source_name": "Seeking Alpha", "published_at": "2026-06-30T11:40:06", "published_display": "30 Jun 2026 11:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Sionna Therapeutics, Inc. \u2013 NASDAQ:SION", "summary": "This article provides a financial snapshot for Sionna Therapeutics, Inc. (NASDAQ:SION), focusing on its forward price-to-earnings ratio. It indicates that the market was closed at the time of publication with no trades, and details are available under the \"Financials\" section. Th", "url": "https://www.tradingview.com/symbols/NASDAQ-SION/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T22:11:30", "published_display": "29 Jun 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics, Inc.(NasdaqGM:SION) dropped from Russell Microcap Growth Benchmark Index", "summary": "Sionna Therapeutics, Inc. (NasdaqGM:SION) has been removed from the Russell Microcap Growth Benchmark Index, as reported on June 28, 2026. This follows other recent removals from related Russell indices. The company, a clinical-stage biopharmaceutical firm focusing on cystic fibr", "url": "https://www.marketscreener.com/news/sionna-therapeutics-inc-nasdaqgm-sion-dropped-from-russell-microcap-growth-benchmark-index-ce7f5fdcd88ef620?utm_source=copy&utm_medium=social&utm_campaign=share", "source_name": "marketscreener.com", "published_at": "2026-06-29T18:40:24", "published_display": "29 Jun 2026 18:40", "sentiment": "negative", "sentiment_pct": 33, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics, Inc.(NasdaqGM: SION) dropped from Russell Microcap Index", "summary": "Sionna Therapeutics, Inc. (NasdaqGM: SION) has been removed from the Russell Microcap Index. The company is a clinical-stage biopharmaceutical firm focused on developing novel medicines for cystic fibrosis, specifically small molecules designed to correct defects caused by the F5", "url": "https://www.marketscreener.com/news/sionna-therapeutics-inc-nasdaqgm-sion-dropped-from-russell-microcap-index-ce7f5fdfda89ff23", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T18:11:08", "published_display": "29 Jun 2026 18:11", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics, Inc. Actuals & Estimates (NASDAQ:SION)", "summary": "This article provides an overview of Sionna Therapeutics, Inc. (SION) stock, including its current price, historical performance, and analyst forecasts. It also covers financial details such as market capitalization, upcoming earnings reports, past earnings, revenue, and net inco", "url": "https://www.tradingview.com/symbols/NASDAQ-SION/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T21:10:56", "published_display": "25 Jun 2026 21:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SION Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Sionna Therapeutics, Inc. (SION) stock, including analyst price targets, current stock performance, and financial data. It highlights that the stock has seen significant increases over the past year and details upcoming earnings dates, recent ", "url": "https://www.tradingview.com/symbols/NASDAQ-SION/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T15:39:12", "published_display": "25 Jun 2026 15:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Sionna Therapeutics, Inc. (SION) and Crescent Biopharma (CBIO)", "summary": "Three analysts have provided bullish insights on several healthcare companies. Gary Nachman of Canaccord Genuity reiterated a Buy rating for AbbVie (ABBV) with a $273 price target. Yatin Suneja of Guggenheim maintained a Buy rating on Sionna Therapeutics, Inc. (SION) with a $50 p", "url": "https://www.theglobeandmail.com/investing/markets/stocks/ABBV/pressreleases/2623269/analysts-offer-insights-on-healthcare-companies-abbvie-abbv-sionna-therapeutics-inc-sion-and-crescent-biopharma-cbio/", "source_name": "The Globe and Mail", "published_at": "2026-06-25T05:40:11", "published_display": "25 Jun 2026 05:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citizens reiterates Sionna Therapeutics stock rating ahead of summer data By Investing.com", "summary": "Citizens has reaffirmed its Market Outperform rating and $63.00 price target for Sionna Therapeutics (NASDAQ: SION) ahead of key summer data readouts. The firm anticipates two significant readouts this summer that will influence the design of a Phase 2b cystic fibrosis trial, com", "url": "https://ng.investing.com/news/stock-market-news/citizens-reiterates-sionna-therapeutics-stock-rating-ahead-of-summer-data-93CH-2569355", "source_name": "Investing.com Nigeria", "published_at": "2026-06-24T02:40:41", "published_display": "24 Jun 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citizens reiterates Sionna Therapeutics stock rating ahead of summer data", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNOUxvalZWakRMb3BGZXlCSjVnQ0lmR0p3U3RUY3V1ZXhMVjJRaXZMeEdKYzVRZmxxTXVib0hxOWxBNHlta0VXUHlCbHU1aUtvRmlkbjE1RHE4MlFNbDlMZUd4Q1hzcWJzWlZaa3RlLVZoejExckRrS1dMZFhYd0xnMFdHWUVfejd1aVBOVmxWYVd1a0dEYXFlbmoxUXY5NktQSVJzSnZSTDZIaTI5MnozV3JsUzRTMTl0ejFNajhrQlYyLWpjLVZVaTVQRW04Zw?oc=5", "source_name": "Investing.com", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is TG Therapeutics, Inc. (TGTX) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOM3V1aXM2YlBCd3VlVzVNX3dfa09LeEk5YkZ2dVVCUW1rQXFqUW5rbFoxME5CUGVGR2JpT2RwTE44S2w4T0FpUElyNno2V2lSZTIzMmtxdl9Tb3FhV0RyeEZPTTNPbGRIcU5CamZmUGxUZjhObG83X2ptYl82dWlmY21hWmYxaVRqbVVlRHRoS29xSVdESEQtSFhR?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWkdoUDRJdkh3QndoZ3J2OHBvOEJlMUFEYjc1X3pLZGFXUlJ6eS1iNXhpYzNyd1NSZGxPOUdDM0xnZW9RcS1kdWNwR0xydVFVcEFGVmhfWWF5SFhYTmR5dXM0cTRIUENtbTc5bUpuNTNZQ0h0QWhMbnZDdGpfYjRWM2c3SWlCOHVJYTVoaUdDYnk2cTRKWWZTZHFvXzZDMTFmOGRUUUhyX3J6RUE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Sionna Therapeutics (SION) Valuation After A Mixed Period For Recent Share Price Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPRGpITG1kMWZLZDhXaWNVS0J1MVNmcmNweTB3ZHowMDFiR0Z6RnAxRHBSNkNCaWlWUTFYNTNHSHY0bUUxamtRRjMxVFVXNjNzM2l5YXNiYXNxblN2UTFpVi1BcEVXblZrWlhOaExZS0pfOUVKRWczLUlOcFJHNXZWZmVCN2pBTVIyRmhoX1psWmtPWm8xTVVxTldEejA5dmgxMmE3c0tmNUFYR1hxZGR3NzZEZw?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stock market today: S&P 500, Nasdaq lead another record-setting stock surge amid US-Iran deal hopes, software stocks rally", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggJBVV95cUxQNzRRLVpuSzR1VkkySTA1RG1RWW92Tm9sU19GZkpLOXZwQjJ0WDAzV0xUbmFUMjIzZjkxN3BSVk5NaFg5MUF1Q2lpa3FwbFNzODRvQ2YzZElpUlRsaC1IYjQ0b3JHM2g1MnNTd2tCd09rLUliZWdmRjNtN1NQT0U4bm9OdHYxTlJpMFhjR1cwNWptX1RLcDc3a3ZFcTEzR2tTVWxjV1lUQ1VhTDZyU1Y0WUJIdThXMF9IVEZUSzlQeXRONzdWdGdNRmtZMEgwSmtkSVpPZV9oRTFhYkVrYmlzSUhjWlphZWJROTZGZXpvd0Y4a3p0TFZ5dG41LWxTVmZRTmc?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences", "summary": "", "url": "https://finance.yahoo.com/news/sionna-therapeutics-participate-upcoming-june-120000855.html", "source_name": "GlobeNewswire", "published_at": "2026-05-27T12:00:00+00:00", "published_display": "27 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Wedbush Initiates Coverage of Sionna Therapeutics (SION)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQZlA3aWw0UW1kcGpyN0JEdEdSMDhmUGJGOWV2NGtKZklDY2Y4QmwwcS1iWFJpRmRla2RNdV9IM0R2LS1HYy1FMTJhbDNaa0NGbTc1QmNFN1A0QnNYWkp4R2hmNnlsbUJPN2xQeXI2RTFJSGczV2JzZFRqd2RCcWpTMWw0OUpxV0M5Z2t2WjlQa1kwcUZjcC1XaVpoVjY2aVFFdTRoR3ZHM2JfY1hQR2hHM3FaV1ZfQQ?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/news/sionna-therapeutics-participate-2026-rbc-120000467.html", "source_name": "GlobeNewswire", "published_at": "2026-05-13T12:00:00+00:00", "published_display": "13 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics Q1 Net Loss Narrows", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/sionna-therapeutics-q1-net-loss-113625258.html", "source_name": "MT Newswires", "published_at": "2026-05-12T11:36:25+00:00", "published_display": "12 May 2026 11:36", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/sionna-therapeutics-reports-first-quarter-110000644.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T11:00:00+00:00", "published_display": "12 May 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Stock market today: S&P 500, Nasdaq post 6th weekly win as chip stocks rally, jobs data boosts sentiment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8wFBVV95cUxOemJZVUVtWVBuQmlKNmx4UjV1OUM5d0xnTENEbUd5YnNKaHBCYnFfdXVrNS1qc05WX2V3VmdQZTBwODBaQXVDcERCenFVVkFMSWJIWWs2YXVuWUpkbV9wemZLTWw0eE5pUExrWFV5MXpTV3hZVTRJMjFyZU1zZEtQV2JHMW5xZ0JpNEg4TEhNMEFOb0x3MmpzcFJkaU83d3ZCWUNUclcxZlJRaUg5NHFzNEJzeWlVYkRLUWVESnI0SEtRRndkNUpuTHZSZmhJSDV0NVl5RWdLY1Z0N1VhUUNXdVVHTlRzd0FXYnRmQmt6SV9QVWs?oc=5", "source_name": "Market source", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Sionna Therapeutics (SION) Valuation After Its Strong 1 Year Return And Premium P/B Ratio", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQOWVQWUU5dF9WV3FtSEJjdE5CTnJNX0xURDdTN3BuaV91NUtVSkFkcEhuTTdId21zOHFrQzRBLVh1WWc0RVRwQWR0by11eDVnQm4zdEtjQUlnQTlxMGlhaThYajNRTUdwS0ZOTWpUdHgySkUxUHprRkY3eDc3dTRjTkdsQ3d3Zm94ek9TcDAxdmVGVWZoM0xCU0hDV0MyalBjUGF0V1pWVQ?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First trial of Sionna's CF add-on drug reaches full enrollment", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQX09CeTJ5eVQ3RFE3cE9jYlpJNlRkSlhWbjhXczl3OGx0OU9EQmIzdV8wTllpZldwM1c3Y1RreXJkZ2Q2aGFibXJBZ0RhZjVFY0lSZ0VzWXZ1ejZQcWFFbk9xcGJUeFlHWWxqdWZaRTkxeTBqbFBQb0Rxb2FjN1hXUVN3M1BWVmlzRUFYb2o0bks2SF9UTXJJUy1BMHNwU0l0enFnZTZGLTd5UjU5eXg5QVo3YzZERE1RMG9wVk93?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Sionna Therapeutics Inc. (SION) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUkFVX3lxTE5uUUFrVjJCeEk4c2VFdFlMSkZTMlBHSEhTb0JTdko0TW4wekd2WkkwOVpHNGlmRWpyZWxJdGYtVWlHbDNYYUFidDRtYW83QXhUNmc?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-20T17:55:03+00:00", "published_display": "20 Jul 2026 17:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics (SION) Stock Looks Pricey On Assets But Strong On Returns", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-19T03:38:58+00:00", "published_display": "19 Jul 2026 03:38", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SION Stock Jumps As Traders Bet On High-Volatility Setup", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQNkpaS2o0MzNldnlzVF9XX01vcVVZVnRZczIzX0pKeEZRQ1B2aDZPeVhOa2E5QWk3TjhyckJNem1tazZqSzRlb29aaWFQSzhwLTFXSDRkM1ZadVpkUkhQaGR0T1V6OGRQNloyUHpSUnBZalpyZnZsczZRY2lZQUxYMGxDVQ?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-18T14:08:00+00:00", "published_display": "18 Jul 2026 14:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SION Jumps As Sionna Therapeutics Draws Trader Attention", "summary": "Sionna Therapeutics Inc. (SION) stock has surged by 11.26% due to positive cystic fibrosis drug development news. Despite being a pre-revenue biotech with negative earnings and cash burn, its strong balance sheet with low debt and high liquidity makes it a high-risk, high-reward ", "url": "https://stockstotrade.com/news/sionnatherapeuticsinc-sion-news-2026_07_18/", "source_name": "StocksToTrade", "published_at": "2026-07-18T12:09:22", "published_display": "18 Jul 2026 12:09", "sentiment": "positive", "sentiment_pct": 73, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SION Jumps As Sionna Therapeutics Stock Extends Breakout", "summary": "Sionna Therapeutics Inc. (SION) stock jumped over 11% following positive developments in its cystic fibrosis pipeline, signaling increased investor confidence. The stock showed strong technical breakout from the low-$40s to the $50 area, driven by aggressive buying and short cove", "url": "https://stockstotrade.com/news/sionnatherapeuticsinc-sion-news-2026_07_18-2/", "source_name": "StocksToTrade", "published_at": "2026-07-18T11:48:00", "published_display": "18 Jul 2026 11:48", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$SION stock is up 9% today. Here's what we see in our data.", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQZ29sbnA0azBRVEh1b1Vqci0tS3lUdjRoMjZUUzg0ZnBtcXpJcFZKRmRVaExkRzl5UjBOTlF6R2xlbk9hbnNuWWhJS3BSYjZwbWp3QUNONXlicEltaEJtQlhIUzlPdGJBNjFMYlh2a3JqdXpRb2syMFBYZ2pCXzNTcy1oUGw3SFU5OGNNYi03V1IyaW5ZXzFSNXdQenN2WlE?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-17T19:23:00+00:00", "published_display": "17 Jul 2026 19:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics (SION) Sees 9.2% Surge in Stock Price", "summary": "Sionna Therapeutics (SION) experienced a 9.2% surge in its stock price, reaching $49.44, driven by positive investor sentiment and developments in its biotechnology focus on cystic fibrosis treatments. Despite this gain, the company holds a low GF Score\u2122 of 12/100, indicating pro", "url": "https://www.gurufocus.com/news/8964925/sionna-therapeutics-sion-sees-92-surge-in-stock-price?mobile=true", "source_name": "GuruFocus", "published_at": "2026-07-17T18:39:32", "published_display": "17 Jul 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics stock hits all-time high at 48.66 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQSHR3bHRtc1BuRWtWSk1ZbFBVanBFUTQxdU5yUml4aDU3ZVl4bTNMM2tmMjVQeWt4OC00S3ZtUlV2QjVEWEdrN2VISXVVSUI5NWlOZlROeHE5MEoxRkxWLUFoZm9HZ3pjdkJlYkxyVVhlR3JFWDNCUEFJN3FYWGI1NllUbUdfV2I5elk0OWFLZnpHTmJ6UXQ5clduaU0xRjd5S0gtNDJ6Tl9xMjlwMlpCS1FR?oc=5", "source_name": "Investing.com", "published_at": "2026-07-17T16:22:08+00:00", "published_display": "17 Jul 2026 16:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics stock hits all-time high at 48.66 USD By Investing.com", "summary": "Sionna Therapeutics (SION) stock has reached an all-time high of $48.66, marking a 147% total return over the past year and achieving a market capitalization of $2.04 billion. Analyst ratings vary, with Citizens and Stifel maintaining \"Outperform\" and \"Buy\" ratings respectively, ", "url": "https://m.za.investing.com/news/stock-market-news/sionna-therapeutics-stock-hits-alltime-high-at-4866-usd-93CH-4374753?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-07-17T15:39:32", "published_display": "17 Jul 2026 15:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orbimed Advisors LLC Reduces Stake in Sionna Therapeutics Inc", "summary": "Orbimed Advisors LLC recently reduced its stake in Sionna Therapeutics Inc by selling 85,918 shares at $44.86 per share. Despite this reduction, Sionna Therapeutics remains a significant holding (2.2% of the portfolio) for Orbimed, a healthcare investment firm with $15 billion in", "url": "https://www.gurufocus.com/news/8961467/orbimed-advisors-llc-reduces-stake-in-sionna-therapeutics-inc?mobile=true", "source_name": "GuruFocus", "published_at": "2026-07-16T01:42:13", "published_display": "16 Jul 2026 01:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics, Inc. Common Stock (SION) Stock Price Today: $42.59", "summary": "This article provides details on Sionna Therapeutics, Inc. (SION) stock, including its current price of $42.59 and key financial fundamentals like market capitalization ($1.98B) and P/E ratio. It also outlines how to buy SION stock through the Gotrade app, explains that SION does", "url": "https://www.heygotrade.com/en/us-stock/sion/", "source_name": "Gotrade", "published_at": "2026-07-15T03:48:05", "published_display": "15 Jul 2026 03:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics(SION.US) Director Sells US$3.85 Million in Common Stock", "summary": "A director at Sionna Therapeutics (SION.US) recently sold common stock valued at US$3.85 million. This insider transaction indicates a significant divestment by a key individual associated with the company. Investors often monitor such sales for insights into a company's financia", "url": "https://www.moomoo.com/news/post/72735499/sionna-therapeutics-sionus-director-sells-us-3-85-million-in", "source_name": "Moomoo", "published_at": "2026-07-10T09:10:58", "published_display": "10 Jul 2026 09:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Sionna Therapeutics Inc For: 9 July By Investing.com", "summary": "This article announces a Form 4 filing for Sionna Therapeutics Inc. on July 9th, as reported by Investing.com. It is a brief, factual announcement without further details within the main article text, which primarily serves as a placeholder for the filing. The article is part of ", "url": "https://ng.investing.com/news/stock-market-news/form-4-sionna-therapeutics-inc-for-9-july-93CH-2593942", "source_name": "Investing.com Nigeria", "published_at": "2026-07-10T02:09:28", "published_display": "10 Jul 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics Insider Sold Shares Worth $3,854,281, According to a Recent SEC Filing", "summary": "This article reports that an insider at Sionna Therapeutics sold shares valued at $3,854,281. This information is based on a recent SEC filing. The company is Sionna Therapeutics.", "url": "https://www.moomoo.com/news/post/72735705/sionna-therapeutics-insider-sold-shares-worth-3854281-according-to-a", "source_name": "Moomoo", "published_at": "2026-07-09T22:40:55", "published_display": "09 Jul 2026 22:40", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics (SION) Jefferies Global Healthcare Conference 2026 Summary", "summary": "Sionna Therapeutics presented at the Jefferies Global Healthcare Conference 2026, outlining its strategy to revolutionize cystic fibrosis treatment by targeting the NBD1 region of the CFTR protein. The company highlighted its scientific approach with differentiated NBD1 stabilize", "url": "https://quartr.com/events/sionna-therapeutics-sion-jefferies-global-healthcare-conference-2026_F6UlgRPm", "source_name": "Quartr", "published_at": "2026-07-09T10:42:13", "published_display": "09 Jul 2026 10:42", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Sionna Therapeutics Inc For: 7 July By Investing.com", "summary": "This article from Investing.com is a regulatory filing update, announcing the Form 4 for Sionna Therapeutics Inc. The filing date is listed as July 7. The content is primarily a placeholder for the filing, mentioning the company's stock symbol SION.", "url": "https://ng.investing.com/news/stock-market-news/form-4-sionna-therapeutics-inc-for-7-july-93CH-2589853", "source_name": "Investing.com Nigeria", "published_at": "2026-07-08T08:40:44", "published_display": "08 Jul 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics CLO Jennifer Fitzpatrick sells $446k in stock By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPV2NYei1CUEJvYzhQMm41NEFrSDB3STRRaVZ2SFRicWtyQXdfenNGTlFSUU9LZ19HMUs5RDZLaWtDY3BIUXIwSjh6NUwwenhkNEFhaXZUTFdMVzQxTHZoMUtmaUg4SU80UXEyMFV3RXM5NUVnQjk3QWhDUTlZUnMtU3ZWRWRfZ0o5RFVGZkwwakNlLVk2LXVxcWg5NlBRV0FkX2IwQjhaMFh1dFp6SHV6UF9OclEyY21mcV8zQllnYTRkUWs?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T21:09:31+00:00", "published_display": "07 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics Insider Sold Shares Worth $446,862, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/sionna-therapeutics-insider-sold-shares-204144056.html", "source_name": "MT Newswires", "published_at": "2026-07-07T20:41:44+00:00", "published_display": "07 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics CLO Jennifer Fitzpatrick sells $446k in stock", "summary": "Jennifer Fitzpatrick, CLO of Sionna Therapeutics (NASDAQ:SION), sold 10,250 shares of company stock for $446,862 on July 6, 2026, after exercising options. The sale was executed under a Rule 10b5-1 trading plan, with the stock currently trading near its 52-week high and Investing", "url": "https://www.investing.com/news/insider-trading-news/sionna-therapeutics-clo-jennifer-fitzpatrick-sells-446k-in-stock-93CH-4780175", "source_name": "Investing.com", "published_at": "2026-07-07T21:40:44", "published_display": "07 Jul 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Sionna Therapeutics, Inc. Stocks", "summary": "This article lists various ETFs that include Sionna Therapeutics, Inc. (SION) stocks in their holdings. The ETFs are sorted by market value and provide details such as issuer, management style, expense ratio, AUM, price, and 3-year NAV total return. The information aims to help i", "url": "https://www.tradingview.com/symbols/NASDAQ-SION/etfs/", "source_name": "TradingView", "published_at": "2026-07-03T23:09:43", "published_display": "03 Jul 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Sionna Therapeutics Inc For: 2 July By Investing.com", "summary": "This article announces the filing of Form 4 by Sionna Therapeutics Inc. for July 2nd, as reported by Investing.com. It is a brief financial news update indicating a disclosure filing from the company to the SEC. The content provides minimal detail beyond the announcement of the f", "url": "https://uk.investing.com/news/stock-market-news/form-4-sionna-therapeutics-inc-for-2-july-93CH-4755750", "source_name": "Investing.com UK", "published_at": "2026-07-03T19:40:01", "published_display": "03 Jul 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics director Thompson sells $5.27m in stock", "summary": "Peter A. Thompson, a director at Sionna Therapeutics (NASDAQ:SION), has sold 115,844 shares of common stock for approximately $5.27 million, through a Rule 10b5-1 trading plan. This transaction, reported on June 30, 2026, occurred while the stock was trading at $45.50 per share, ", "url": "https://www.investing.com/news/insider-trading-news/sionna-therapeutics-director-thompson-sells-527m-in-stock-93CH-4774244", "source_name": "Investing.com", "published_at": "2026-07-02T21:39:41", "published_display": "02 Jul 2026 21:39", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SION - Sionna Therapeutics Inc Latest SEC Filings", "summary": "This article provides the latest SEC filings for Sionna Therapeutics Inc (SION), along with comprehensive financial data, stock performance metrics, and analyst ratings. It details the company's market capitalization, income, sales, insider and institutional ownership, and variou", "url": "https://finviz.com/stock?t=SION&ta=1&p=w&ty=lf&r=y2&page=1", "source_name": "Finviz", "published_at": "2026-07-02T06:39:41", "published_display": "02 Jul 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Sionna Therapeutics, Inc. \u2013 NASDAQ:SION", "summary": "This article focuses on the enterprise value to EBITDA forward of Sionna Therapeutics, Inc. (NASDAQ: SION). The content appears to be a financial data page from TradingView, indicating that the market for SION was closed with no trades at the time of publication.", "url": "https://www.tradingview.com/symbols/NASDAQ-SION/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T22:09:47", "published_display": "01 Jul 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Sionna Therapeutics, Inc. \u2013 NASDAQ:SION", "summary": "The article focuses on the enterprise value to revenue forward metric for Sionna Therapeutics, Inc. (NASDAQ: SION). It provides a snapshot of the company's financial overview within the health technology and biotechnology sector on the Nasdaq Stock Market. The page appears to be ", "url": "https://www.tradingview.com/symbols/NASDAQ-SION/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T21:09:48", "published_display": "01 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SION - Sionna Therapeutics Inc Options", "summary": "This article provides detailed financial data and performance metrics for Sionna Therapeutics Inc. (SION). It includes key financial figures such as market cap, income, sales, EPS, and various ratios, alongside stock performance, insider and institutional ownership, and analyst r", "url": "https://finviz.com/stock?t=SION&p=w&r=y2&ty=oc&ov=chain_strike&s=25", "source_name": "Finviz", "published_at": "2026-07-01T17:09:47", "published_display": "01 Jul 2026 17:09", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SION - Sionna Therapeutics Inc Short Interest", "summary": "This article provides a detailed overview of Sionna Therapeutics Inc. (SION)'s short interest and key financial metrics. It includes stock performance data, insider and institutional ownership percentages, and analytical figures such as P/E ratios and debt/equity. The information", "url": "https://finviz.com/stock?t=SION&ta=1&p=w&ty=si&r=y2", "source_name": "Finviz", "published_at": "2026-07-01T13:09:24", "published_display": "01 Jul 2026 13:09", "sentiment": "negative", "sentiment_pct": 38, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Sionna Therapeutics, Inc. \u2013 NASDAQ:SION", "summary": "The article focuses on the \"Price to sales forward\" metric for Sionna Therapeutics, Inc. (NASDAQ: SION). It presents this financial data point within the context of the company's profile on TradingView, indicating its relevance for investors analyzing the biotechnology sector. Th", "url": "https://www.tradingview.com/symbols/NASDAQ-SION/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T09:09:24", "published_display": "01 Jul 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics: NBD1 Stabilization Could Redefine Cystic Fibrosis Treatment (SION)", "summary": "Sionna Therapeutics is developing a novel approach to treat cystic fibrosis by stabilizing NBD1, aiming to improve CFTR function beyond existing treatments. The company has two key drug candidates, SION-719 and SION-451, both nearing significant clinical data readouts in summer 2", "url": "https://seekingalpha.com/article/4918780-sionna-therapeutics-stock-nbd1-stabilization-could-redefine-cystic-fibrosis-treatment", "source_name": "Seeking Alpha", "published_at": "2026-06-30T11:40:06", "published_display": "30 Jun 2026 11:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Sionna Therapeutics, Inc. \u2013 NASDAQ:SION", "summary": "This article provides a financial snapshot for Sionna Therapeutics, Inc. (NASDAQ:SION), focusing on its forward price-to-earnings ratio. It indicates that the market was closed at the time of publication with no trades, and details are available under the \"Financials\" section. Th", "url": "https://www.tradingview.com/symbols/NASDAQ-SION/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T22:11:30", "published_display": "29 Jun 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics, Inc.(NasdaqGM:SION) dropped from Russell Microcap Growth Benchmark Index", "summary": "Sionna Therapeutics, Inc. (NasdaqGM:SION) has been removed from the Russell Microcap Growth Benchmark Index, as reported on June 28, 2026. This follows other recent removals from related Russell indices. The company, a clinical-stage biopharmaceutical firm focusing on cystic fibr", "url": "https://www.marketscreener.com/news/sionna-therapeutics-inc-nasdaqgm-sion-dropped-from-russell-microcap-growth-benchmark-index-ce7f5fdcd88ef620?utm_source=copy&utm_medium=social&utm_campaign=share", "source_name": "marketscreener.com", "published_at": "2026-06-29T18:40:24", "published_display": "29 Jun 2026 18:40", "sentiment": "negative", "sentiment_pct": 33, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics, Inc.(NasdaqGM: SION) dropped from Russell Microcap Index", "summary": "Sionna Therapeutics, Inc. (NasdaqGM: SION) has been removed from the Russell Microcap Index. The company is a clinical-stage biopharmaceutical firm focused on developing novel medicines for cystic fibrosis, specifically small molecules designed to correct defects caused by the F5", "url": "https://www.marketscreener.com/news/sionna-therapeutics-inc-nasdaqgm-sion-dropped-from-russell-microcap-index-ce7f5fdfda89ff23", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T18:11:08", "published_display": "29 Jun 2026 18:11", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics, Inc. Actuals & Estimates (NASDAQ:SION)", "summary": "This article provides an overview of Sionna Therapeutics, Inc. (SION) stock, including its current price, historical performance, and analyst forecasts. It also covers financial details such as market capitalization, upcoming earnings reports, past earnings, revenue, and net inco", "url": "https://www.tradingview.com/symbols/NASDAQ-SION/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T21:10:56", "published_display": "25 Jun 2026 21:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SION Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Sionna Therapeutics, Inc. (SION) stock, including analyst price targets, current stock performance, and financial data. It highlights that the stock has seen significant increases over the past year and details upcoming earnings dates, recent ", "url": "https://www.tradingview.com/symbols/NASDAQ-SION/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T15:39:12", "published_display": "25 Jun 2026 15:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Sionna Therapeutics, Inc. (SION) and Crescent Biopharma (CBIO)", "summary": "Three analysts have provided bullish insights on several healthcare companies. Gary Nachman of Canaccord Genuity reiterated a Buy rating for AbbVie (ABBV) with a $273 price target. Yatin Suneja of Guggenheim maintained a Buy rating on Sionna Therapeutics, Inc. (SION) with a $50 p", "url": "https://www.theglobeandmail.com/investing/markets/stocks/ABBV/pressreleases/2623269/analysts-offer-insights-on-healthcare-companies-abbvie-abbv-sionna-therapeutics-inc-sion-and-crescent-biopharma-cbio/", "source_name": "The Globe and Mail", "published_at": "2026-06-25T05:40:11", "published_display": "25 Jun 2026 05:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citizens reiterates Sionna Therapeutics stock rating ahead of summer data By Investing.com", "summary": "Citizens has reaffirmed its Market Outperform rating and $63.00 price target for Sionna Therapeutics (NASDAQ: SION) ahead of key summer data readouts. The firm anticipates two significant readouts this summer that will influence the design of a Phase 2b cystic fibrosis trial, com", "url": "https://ng.investing.com/news/stock-market-news/citizens-reiterates-sionna-therapeutics-stock-rating-ahead-of-summer-data-93CH-2569355", "source_name": "Investing.com Nigeria", "published_at": "2026-06-24T02:40:41", "published_display": "24 Jun 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citizens reiterates Sionna Therapeutics stock rating ahead of summer data", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNOUxvalZWakRMb3BGZXlCSjVnQ0lmR0p3U3RUY3V1ZXhMVjJRaXZMeEdKYzVRZmxxTXVib0hxOWxBNHlta0VXUHlCbHU1aUtvRmlkbjE1RHE4MlFNbDlMZUd4Q1hzcWJzWlZaa3RlLVZoejExckRrS1dMZFhYd0xnMFdHWUVfejd1aVBOVmxWYVd1a0dEYXFlbmoxUXY5NktQSVJzSnZSTDZIaTI5MnozV3JsUzRTMTl0ejFNajhrQlYyLWpjLVZVaTVQRW04Zw?oc=5", "source_name": "Investing.com", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is TG Therapeutics, Inc. (TGTX) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOM3V1aXM2YlBCd3VlVzVNX3dfa09LeEk5YkZ2dVVCUW1rQXFqUW5rbFoxME5CUGVGR2JpT2RwTE44S2w4T0FpUElyNno2V2lSZTIzMmtxdl9Tb3FhV0RyeEZPTTNPbGRIcU5CamZmUGxUZjhObG83X2ptYl82dWlmY21hWmYxaVRqbVVlRHRoS29xSVdESEQtSFhR?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWkdoUDRJdkh3QndoZ3J2OHBvOEJlMUFEYjc1X3pLZGFXUlJ6eS1iNXhpYzNyd1NSZGxPOUdDM0xnZW9RcS1kdWNwR0xydVFVcEFGVmhfWWF5SFhYTmR5dXM0cTRIUENtbTc5bUpuNTNZQ0h0QWhMbnZDdGpfYjRWM2c3SWlCOHVJYTVoaUdDYnk2cTRKWWZTZHFvXzZDMTFmOGRUUUhyX3J6RUE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Sionna Therapeutics (SION) Valuation After A Mixed Period For Recent Share Price Returns", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPRGpITG1kMWZLZDhXaWNVS0J1MVNmcmNweTB3ZHowMDFiR0Z6RnAxRHBSNkNCaWlWUTFYNTNHSHY0bUUxamtRRjMxVFVXNjNzM2l5YXNiYXNxblN2UTFpVi1BcEVXblZrWlhOaExZS0pfOUVKRWczLUlOcFJHNXZWZmVCN2pBTVIyRmhoX1psWmtPWm8xTVVxTldEejA5dmgxMmE3c0tmNUFYR1hxZGR3NzZEZw?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stock market today: S&P 500, Nasdaq lead another record-setting stock surge amid US-Iran deal hopes, software stocks rally", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggJBVV95cUxQNzRRLVpuSzR1VkkySTA1RG1RWW92Tm9sU19GZkpLOXZwQjJ0WDAzV0xUbmFUMjIzZjkxN3BSVk5NaFg5MUF1Q2lpa3FwbFNzODRvQ2YzZElpUlRsaC1IYjQ0b3JHM2g1MnNTd2tCd09rLUliZWdmRjNtN1NQT0U4bm9OdHYxTlJpMFhjR1cwNWptX1RLcDc3a3ZFcTEzR2tTVWxjV1lUQ1VhTDZyU1Y0WUJIdThXMF9IVEZUSzlQeXRONzdWdGdNRmtZMEgwSmtkSVpPZV9oRTFhYkVrYmlzSUhjWlphZWJROTZGZXpvd0Y4a3p0TFZ5dG41LWxTVmZRTmc?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences", "summary": "", "url": "https://finance.yahoo.com/news/sionna-therapeutics-participate-upcoming-june-120000855.html", "source_name": "GlobeNewswire", "published_at": "2026-05-27T12:00:00+00:00", "published_display": "27 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wedbush Initiates Coverage of Sionna Therapeutics (SION)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQZlA3aWw0UW1kcGpyN0JEdEdSMDhmUGJGOWV2NGtKZklDY2Y4QmwwcS1iWFJpRmRla2RNdV9IM0R2LS1HYy1FMTJhbDNaa0NGbTc1QmNFN1A0QnNYWkp4R2hmNnlsbUJPN2xQeXI2RTFJSGczV2JzZFRqd2RCcWpTMWw0OUpxV0M5Z2t2WjlQa1kwcUZjcC1XaVpoVjY2aVFFdTRoR3ZHM2JfY1hQR2hHM3FaV1ZfQQ?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/news/sionna-therapeutics-participate-2026-rbc-120000467.html", "source_name": "GlobeNewswire", "published_at": "2026-05-13T12:00:00+00:00", "published_display": "13 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics Q1 Net Loss Narrows", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/sionna-therapeutics-q1-net-loss-113625258.html", "source_name": "MT Newswires", "published_at": "2026-05-12T11:36:25+00:00", "published_display": "12 May 2026 11:36", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sionna Therapeutics Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/sionna-therapeutics-reports-first-quarter-110000644.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T11:00:00+00:00", "published_display": "12 May 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stock market today: S&P 500, Nasdaq post 6th weekly win as chip stocks rally, jobs data boosts sentiment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8wFBVV95cUxOemJZVUVtWVBuQmlKNmx4UjV1OUM5d0xnTENEbUd5YnNKaHBCYnFfdXVrNS1qc05WX2V3VmdQZTBwODBaQXVDcERCenFVVkFMSWJIWWs2YXVuWUpkbV9wemZLTWw0eE5pUExrWFV5MXpTV3hZVTRJMjFyZU1zZEtQV2JHMW5xZ0JpNEg4TEhNMEFOb0x3MmpzcFJkaU83d3ZCWUNUclcxZlJRaUg5NHFzNEJzeWlVYkRLUWVESnI0SEtRRndkNUpuTHZSZmhJSDV0NVl5RWdLY1Z0N1VhUUNXdVVHTlRzd0FXYnRmQmt6SV9QVWs?oc=5", "source_name": "Market source", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Sionna Therapeutics (SION) Valuation After Its Strong 1 Year Return And Premium P/B Ratio", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQOWVQWUU5dF9WV3FtSEJjdE5CTnJNX0xURDdTN3BuaV91NUtVSkFkcEhuTTdId21zOHFrQzRBLVh1WWc0RVRwQWR0by11eDVnQm4zdEtjQUlnQTlxMGlhaThYajNRTUdwS0ZOTWpUdHgySkUxUHprRkY3eDc3dTRjTkdsQ3d3Zm94ek9TcDAxdmVGVWZoM0xCU0hDV0MyalBjUGF0V1pWVQ?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First trial of Sionna's CF add-on drug reaches full enrollment", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQX09CeTJ5eVQ3RFE3cE9jYlpJNlRkSlhWbjhXczl3OGx0OU9EQmIzdV8wTllpZldwM1c3Y1RreXJkZ2Q2aGFibXJBZ0RhZjVFY0lSZ0VzWXZ1ejZQcWFFbk9xcGJUeFlHWWxqdWZaRTkxeTBqbFBQb0Rxb2FjN1hXUVN3M1BWVmlzRUFYb2o0bks2SF9UTXJJUy1BMHNwU0l0enFnZTZGLTd5UjU5eXg5QVo3YzZERE1RMG9wVk93?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcjZqdzdBcURDdWxCZUtoU1dTaHYtVUFRdlo1a3ZGZGY3a1dBX2x2UVE3Y1hoX1duLXhGU2p0UXU2eTctNng5eFJ5c1M0bHBNQ0VmZTFZanhYU21yTVo0UTQtVENveVV1aWdpc3luUlgza3AyUEI2OGx4aEhXc0pBTHpWUThSYXI1S3RTS21lQ21vWjd6MGY4ZDRwVWlEakc3SmFKN09aM0Rlb2pFT3BNNW1GTExnSElFb2NqR3JhX0J3MlptQy1mMk9IOTZtdS1HU25fLU9aOU9XZi1PRDlkZVI2cnhackHSAewBQVVfeXFMTlc2N3pIUkxDd1NtTlVRMEdac1JNSDF3cUNidkZrTElQREZaUTZjZmFHdUVWYW8wcDg1LThGbnlPb0VQUFI4ZXdjSXR6Ym5DREM1X2lyQUtYTzF3XzBBTGRGcEZQQ3FjLWxCQ0locVM2dGZJR1kxYmlBQXdsbFhfbFFISS1wSUkxQmp4U2d2Z3JHbXRPMUpnajBydTRmNnQzZmF5eEdzOVFRNUdDNVV0aDJQNERCaXN3ZGo1UUc1ZGkwOFYzcDgxS1ltZllDeTFxNFIxT3FyOUxLMFNrLUhtOFNFV0xMYkM5TlpWMzk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 104, "total_relevant": 79, "sentiment_summary": {"positive": 21, "negative": 10, "neutral": 48, "score": 54, "total": 79, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 26.55, "count": 47}, {"event": "earnings", "label": "Earnings", "weight": 10.25, "count": 20}, {"event": "analyst", "label": "Analyst action", "weight": 3.3, "count": 6}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 21, "negative_events": 10}, "market_context": {"has_market_context": true, "latest_close": 49.41, "latest_week": "2026-07-17", "one_week_move": 9.1, "four_week_move": 32.5, "twelve_week_move": 29.7, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.817748, "market_dynamics_buy_signal": false, "relative_strength": 24.432972, "fair_value_gap": 68.1, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 49.7425, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+9.1% over one week, +32.5% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 12}, {"label": "TradingView", "count": 8}, {"label": "Investing.com", "count": 4}, {"label": "Investing.com Nigeria", "count": 4}, {"label": "timothysykes.com", "count": 3}, {"label": "simplywall.st", "count": 3}, {"label": "Finviz", "count": 3}, {"label": "GlobeNewswire", "count": 3}], "tiers": [{"label": "Direct company coverage", "count": 71}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 47}, {"label": "Earnings", "count": 20}, {"label": "Analyst action", "count": 6}, {"label": "Balance sheet", "count": 2}, {"label": "Deals and strategy", "count": 2}, {"label": "Regulatory and legal", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "71", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+9.1% over one week, +32.5% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Sionna Therapeutics Inc. (SION) Stock Price | Live Quotes & Charts | NASDAQ"}], "updated_at": "2026-07-21T03:05:19.902613+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}